Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-tumor necrosis factor alpha receptor 2 (anti-TNFR2) antibodies and methods of use thereof to elicit an immune response against a tumor

Humanized anti-tumor necrosis factor alpha receptor 2 (anti-TNFR2) antibodies and methods of use thereof to elicit an immune response against a tumor

US Patent 10988543 · Granted Apr 27, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof2023
CD37 immunotherapeutics and uses thereof2019
B-cell reduction using CD37-specific and CD20-specific binding molecules2018
CD86 antagonist multi-target binding proteins2016
CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereo2015
Antagonists of IL-62014
Single chain multivalent binding proteins with effector function2013
Materials and methods for improved immunoglycoproteins2013
Materials and methods for improved immunoglycoproteins2010